Pharmaceutical preparations, namely, immunosuppressants, pharmaceutical preparations for the treatment of COVID-19, and anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; pharmaceutical preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases

'-19':12 '-6':19,31 '6':17 'adjust':64 'anti':15 'anti-interleukin':14 'antibodi':22,66 'arter':51 'arthriti':39 'auto':77 'auto-immun':76 'caus':28 'covid':11 'cytokin':44 'diseas':27,59,79 'il':18,30 'immun':63,78 'immunosuppress':4 'interleukin':16 'lung':58 'medic':68 'monoclon':21,65 'name':3 'pharmaceut':1,5,33,40,45,52,60,70 'prepar':2,6,34,41,46,53,61,71 'product':32 'purpos':69 'receptor':20 'suppress':43 'treatment':9,25,37,49,56,74

AVTOZMA

Owners

Goods & Services